AIMS/HYPOTHESIS: Alström syndrome is a rare monogenic disorder characterised by retinal dystrophy, deafness and obesity. Patients also have insulin resistance, central obesity and dyslipidaemia, thus showing similarities with type 2 diabetes. Rare mutations in the ALMS1 gene cause severe gene disruption in Alström patients; however, ALMS1 gene polymorphisms are common in the general population. The aim of our study was to determine whether common variants in ALMS1 contribute to susceptibility to type 2 diabetes in the UK population. METHODS: Direct sequencing was performed on coding regions and intron/exon boundaries of the ALMS1 gene in 30 unrelated probands with type 2 diabetes. The linkage disequilibrium (LD; D' and r2) and haplotype structure were examined for the identified variants. The common (minor allele frequency [MAF] >5%) single-nucleotide polymorphisms tagging the common haplotypes (tagged SNPs [tSNPs]) were identified and genotyped in 1985 subjects with type 2 diabetes, 2,047 control subjects and 521 families. RESULTS: We identified 18 variants with MAF between 6 and 38%. Three SNPs efficiently tagged three common haplotypes (rs1881245, rs3820700 and rs1320374). There was no association (all p > 0.05) between the tSNPs and type 2 diabetes in the case-control study and minor alleles of the tSNPs were not overtransmitted to probands with type 2 diabetes in the family study. CONCLUSIONS/ INTERPRETATION: Common variations in the ALMS1 gene were not associated with type 2 diabetes in a large study of a white UK population.
AIMS/HYPOTHESIS: Alström syndrome is a rare monogenic disorder characterised by retinal dystrophy, deafness and obesity. Patients also have insulin resistance, central obesity and dyslipidaemia, thus showing similarities with type 2 diabetes. Rare mutations in the ALMS1 gene cause severe gene disruption in Alström patients; however, ALMS1 gene polymorphisms are common in the general population. The aim of our study was to determine whether common variants in ALMS1 contribute to susceptibility to type 2 diabetes in the UK population. METHODS: Direct sequencing was performed on coding regions and intron/exon boundaries of the ALMS1 gene in 30 unrelated probands with type 2 diabetes. The linkage disequilibrium (LD; D' and r2) and haplotype structure were examined for the identified variants. The common (minor allele frequency [MAF] >5%) single-nucleotide polymorphisms tagging the common haplotypes (tagged SNPs [tSNPs]) were identified and genotyped in 1985 subjects with type 2 diabetes, 2,047 control subjects and 521 families. RESULTS: We identified 18 variants with MAF between 6 and 38%. Three SNPs efficiently tagged three common haplotypes (rs1881245, rs3820700 and rs1320374). There was no association (all p > 0.05) between the tSNPs and type 2 diabetes in the case-control study and minor alleles of the tSNPs were not overtransmitted to probands with type 2 diabetes in the family study. CONCLUSIONS/ INTERPRETATION: Common variations in the ALMS1 gene were not associated with type 2 diabetes in a large study of a white UK population.
Authors: Tom Hearn; Glenn L Renforth; Cosma Spalluto; Neil A Hanley; Karen Piper; Sarah Brickwood; Chris White; Vincent Connolly; James F N Taylor; Isabelle Russell-Eggitt; Dominque Bonneau; Mark Walker; David I Wilson Journal: Nat Genet Date: 2002-04-08 Impact factor: 38.330
Authors: Jan D Marshall; Roderick T Bronson; Gayle B Collin; Anne D Nordstrom; Pietro Maffei; Richard B Paisey; Catherine Carey; Seamus Macdermott; Isabelle Russell-Eggitt; Sarah E Shea; Judy Davis; Sebastian Beck; Gocha Shatirishvili; Cristina Maria Mihai; Maria Hoeltzenbein; Giovanni Battista Pozzan; Ian Hopkinson; Nicola Sicolo; Jürgen K Naggert; Patsy M Nishina Journal: Arch Intern Med Date: 2005-03-28
Authors: T M Frayling; M Walker; M I McCarthy; J C Evans; L I Allen; S Lynn; S Ayres; B Millauer; C Turner; R C Turner; M J Sampson; G A Hitman; S Ellard; A T Hattersley Journal: Diabetes Date: 1999-12 Impact factor: 9.461
Authors: Michael N Weedon; Katharine R Owen; Beverley Shields; Graham Hitman; Mark Walker; Mark I McCarthy; Latisha D Love-Gregory; M Alan Permutt; Andrew T Hattersley; Timothy M Frayling Journal: Diabetes Date: 2004-11 Impact factor: 9.461
Authors: Gayle B Collin; Jan D Marshall; Akihiro Ikeda; W Venus So; Isabelle Russell-Eggitt; Pietro Maffei; Sebastian Beck; Cornelius F Boerkoel; Nicola Sicolo; Mitchell Martin; Patsy M Nishina; Jürgen K Naggert Journal: Nat Genet Date: 2002-04-08 Impact factor: 38.330
Authors: Florence Demenais; Timo Kanninen; Cecilia M Lindgren; Steven Wiltshire; Stéphane Gaget; Candice Dandrieux; Peter Almgren; Marketa Sjögren; Andrew Hattersley; Christian Dina; Tiinamaija Tuomi; Mark I McCarthy; Philippe Froguel; Leif C Groop Journal: Hum Mol Genet Date: 2003-08-01 Impact factor: 6.150
Authors: Tom Hearn; Cosma Spalluto; Victoria J Phillips; Glenn L Renforth; Nane Copin; Neil A Hanley; David I Wilson Journal: Diabetes Date: 2005-05 Impact factor: 9.461
Authors: Jan D Marshall; Jean Muller; Gayle B Collin; Gabriella Milan; Stephen F Kingsmore; Darrell Dinwiddie; Emily G Farrow; Neil A Miller; Francesca Favaretto; Pietro Maffei; Hélène Dollfus; Roberto Vettor; Jürgen K Naggert Journal: Hum Mutat Date: 2015-05-18 Impact factor: 4.878
Authors: Candace M Kammerer; David L Rainwater; Nicolas Gouin; Madhuri Jasti; Kory C Douglas; Amy S Dressen; Prasanth Ganta; John L Vandeberg; Paul B Samollow Journal: J Lipid Res Date: 2010-07-22 Impact factor: 5.922
Authors: Laura B Scheinfeldt; Shameek Biswas; Jennifer Madeoy; Caitlin F Connelly; Eric E Schadt; Joshua M Akey Journal: Mol Biol Evol Date: 2009-03-11 Impact factor: 16.240